Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 26

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 26
---
#### Audit Committee
Our audit committee is responsible for, among other things:

• appointing, approving the compensation of, and assessing the independence of our registered public accounting firm;

• overseeing the work of our registered public accounting firm, including through the receipt and consideration of reports from such firm;

• reviewing and discussing with management and the registered public accounting firm our annual and quarterly financial statements and related disclosures;

• coordinating our Board of Directors’ oversight of our internal control over financial reporting, disclosure controls and procedures and Code of Business Conduct and Ethics;

• discussing our risk management policies and assisting the Board’s oversight of management of material risks the Company is facing, including without limitation material environmental, social and governance exposure that may have a material impact on the Company’s financial statements or finance-related initiatives;

• overseeing the integrity of the Company’s information technology systems and cybersecurity risks;

• meeting independently with our internal auditing staff, if any, registered public accounting firm and management;

• establishing procedures regarding the reporting and treatment of complaints regarding accounting, internal accounting controls and auditing matters;

<div align='center'>18</div>

TABLE OF CONTENTS

• reviewing and discussing our earnings press releases and approving any pre-release of expected financial or business performance;

• overseeing and reviewing our investment policy;

• reviewing and approving or ratifying any related person transactions; and

• preparing the audit committee report required by SEC rules.

Our audit committee currently consists of Ann E. Berman, Peter Feinberg and Laurie B. Keating, with Ms. Berman serving as chair.

All members of our audit committee meet the requirements for financial literacy under the applicable Nasdaq rules and regulations. Our Board of Directors has affirmatively determined that each member of our audit committee qualifies as “independent” under Nasdaq’s heightened standards and Rule 10A-3 of the Exchange Act applicable to audit committee members, and that Ann E. Berman, Peter Feinberg and Laurie B. Keating each qualify as an “audit committee financial expert,” as such term is defined in Item 407(d)(5) of Regulation S-K.

#### Compensation Committee
Our compensation committee is responsible for, among other things:

• reviewing and approving, or recommending for approval by our Board of Directors, the compensation of our Chief Executive Officer and our other executive officers;

• reviewing and approving or making recommendations to the Board of Directors regarding the Company’s equity incentive plans and administrating the Company’s equity incentive plans;

• reviewing and making recommendations to our Board of Directors with respect to director compensation;

• assisting with